EUVIMEDEUVIMED entdecken
Open Access

A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria

Boggarapu Sneha, Murali Narasimhan, Priya Cinna T Durai, Ramachandran Ramakrishnan

Indian Journal of Dermatology · 2024-05 · 69 (3) · 226-231

DOI: 10.4103/ijd.ijd_1199_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Dermatology, online erschienen am 26.06.2024. Verfasst von Boggarapu Sneha und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Scien…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic spontaneous urticaria (CSU) is the most commonly diagnosed skin condition in dermatology outpatient departments. Second-generation antihistamines are shown to be effective in the control of CSU. As per the guidelines, a combination of antihistamines is less recommended due to the lack of synergistic effect, though used widely. Exploring effective treatment options are crucial, given the challenges posed by CSU. Aims and Objectives: To assess the safety and efficacy of Bilastine up-dosing versus combination of 20 mg Bilastine with 5 mg Levocetirizine in the treatment of CSU. Materials and Methods: This prospective randomized non-blinded comparative trial involved 62 patients, with 32 in group A and 30 in group B. Group A received Tablet Bilastine 20 mg bd, while Group B received a combination of Tablet Bilastine 20 mg and Tablet Levocetirizine 5 mg. Urticarial Activity Score 7 was performed at baseline and follow-up visits (every 2 weeks for 6 weeks).

Results

Both groups had a higher number of male patients in the 20–30 years age group. Angioedema was present in 15.6% of group A and 23.3% in group B. After 6 weeks, both the groups showed a significant improvement in UAS 7 scores ( P value

Schlagwörter

Stichwörter der Autor:innen

BilastineUAS7 scorechronic spontaneous urticarialevocetirizineupdosing

Autor:innen und Institutionen

  • From the Department of Dermatology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, Kanchipuram, Chennai, Ta…

Zitieren

APA

Sneha, B., Narasimhan, M., Durai, P. C. T., & Ramakrishnan, R. (2024). A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria. Indian Journal of Dermatology, 69(3), 226-231. https://doi.org/10.4103/ijd.ijd_1199_23

Vancouver

Sneha B, Narasimhan M, Durai PCT, Ramakrishnan R. A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria. Indian Journal of Dermatology. 2024;69(3):226-231. doi:10.4103/ijd.ijd_1199_23

BibTeX
@article{Sneha2024,
  author = {Sneha, Boggarapu and Narasimhan, Murali and Durai, Priya Cinna T and Ramakrishnan, Ramachandran},
  title = {A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria},
  journal = {Indian Journal of Dermatology},
  year = {2024},
  volume = {69},
  number = {3},
  pages = {226--231},
  doi = {10.4103/ijd.ijd_1199_23}
}
Kostenlos starten →